# Monashee Investment Management 13F Q2 2026

Monashee Investment Management LLC reported $59.6 million in 13F securities across 23 positions for the quarter ended June 30, 2026, in a holdings report filed August 13, 2026. Its largest holding was Alphabet Inc at $5.1 million, 8.5% of the reported value. Since Q1 2026 it opened 21 new positions and exited 43.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $59,583,126
- Positions: 23
- Filed: August 13, 2026
- Report type: 13F holdings report
- CIK: 1627608
- Form 13F file number: 028-16854
- CRD number: 163148
- Business address: 75 Park Plaza 4th Floor, Boston, MA 02116
- SEC filing: [0001172661-26-003357](https://www.sec.gov/Archives/edgar/data/1627608/000117266126003357/0001172661-26-003357-index.htm)
- Investment adviser record: [Form ADV on SpecStream](https://specstream.ai/data/investment-advisers/firm/monashee-investment-management-llc-163148)

## Top 23 holdings by value

The largest of 23 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Alphabet Inc](https://specstream.ai/data/institutional-holders/alphabet-inc-02079k404) | DEP SHS RP1/20 A | 100,000 | $5.1 million | New |
| [Alphabet Inc](https://specstream.ai/data/institutional-holders/alphabet-inc-02079k602) | DEP SHS RP1/20 B | 100,000 | $5 million | New |
| [Solid Biosciences Inc](https://specstream.ai/data/institutional-holders/solid-biosciences-inc-83422e204) | COM NEW | 500,000 | $5 million | -920,295 |
| [Digital Rlty TR Inc](https://specstream.ai/data/institutional-holders/digital-rlty-tr-inc-253868103) | COM | 25,000 | $4.5 million | New |
| [Spyre Therapeutics Inc](https://specstream.ai/data/institutional-holders/spyre-therapeutics-inc-00773j202) | COM NEW | 50,000 | $4.4 million | New |
| [Adt Inc Del](https://specstream.ai/data/institutional-holders/adt-inc-del-00090q103) | COM | 600,000 | $3.9 million | -100,000 |
| [Tango Therapeutics Inc](https://specstream.ai/data/institutional-holders/tango-therapeutics-inc-87583x109) | COM | 100,000 | $3.1 million | New |
| [Celcuity Inc](https://specstream.ai/data/institutional-holders/celcuity-inc-15102kab6) | NOTE 0.250% 8/0 (principal) | 2,500,000 | $2.8 million | New |
| [Super Micro Computer Inc](https://specstream.ai/data/institutional-holders/super-micro-computer-inc-86800u500) | 7 DEP CM SR A WI | 50,000 | $2.6 million | New |
| [Legend Biotech Corp](https://specstream.ai/data/institutional-holders/legend-biotech-corp-52490g102) | SPONSORED ADS | 85,385 | $2.5 million | New |
| [Alphabet Inc](https://specstream.ai/data/institutional-holders/alphabet-inc-02079k305) | CAP STK CL A | 6,000 | $2.1 million | New |
| [Alphabet Inc](https://specstream.ai/data/institutional-holders/alphabet-inc-02079k107) | CAP STK CL C | 6,000 | $2.1 million | New |
| [Uniqure NV](https://specstream.ai/data/institutional-holders/uniqure-nv-n90064101) | SHS | 45,000 | $2.1 million | New |
| [Innio NV](https://specstream.ai/data/institutional-holders/innio-nv-n52a8c105) | ORDINARY SHARES | 47,650 | $1.9 million | New |
| [Acadia Rlty TR](https://specstream.ai/data/institutional-holders/acadia-rlty-tr-004239109) | COM SH BEN INT | 85,385 | $1.8 million | New |
| [Pattern Group Inc](https://specstream.ai/data/institutional-holders/pattern-group-inc-70339w104) | COM SER A | 64,039 | $1.6 million | New |
| [Purecycle Technologies Inc](https://specstream.ai/data/institutional-holders/purecycle-technologies-inc-74623vad5) | NOTE 4.750% 7/0 (principal) | 1,500,000 | $1.5 million | New |
| [Moonlake Immunotherapeutics](https://specstream.ai/data/institutional-holders/moonlake-immunotherapeutics-61559x104) | CLASS A ORD | 75,000 | $1.5 million | New |
| [Whitehawk Minerals Corp](https://specstream.ai/data/institutional-holders/whitehawk-minerals-corp-96524t101) | CL A | 51,232 | $1.4 million | New |
| [Taysha Gene Therapies Inc](https://specstream.ai/data/institutional-holders/taysha-gene-therapies-inc-877619106) | COM SHS | 200,000 | $1.4 million | New |
| [Imagenebio Inc](https://specstream.ai/data/institutional-holders/imagenebio-inc-45175g207) | COM | 192,344 | $1.1 million | New |
| [Nuvation Bio Inc](https://specstream.ai/data/institutional-holders/nuvation-bio-inc-67080naa9) | NOTE 0.750% 7/0 (principal) | 1,000,000 | $1.1 million | New |
| [Kardigan Inc](https://specstream.ai/data/institutional-holders/kardigan-inc-485925101) | COM | 42,693 | $1 million | New |

## New positions in Q2 2026

21 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Alphabet Inc](https://specstream.ai/data/institutional-holders/alphabet-inc-02079k404) | DEP SHS RP1/20 A | 100,000 | $5.1 million |
| [Alphabet Inc](https://specstream.ai/data/institutional-holders/alphabet-inc-02079k602) | DEP SHS RP1/20 B | 100,000 | $5 million |
| [Digital Rlty TR Inc](https://specstream.ai/data/institutional-holders/digital-rlty-tr-inc-253868103) | COM | 25,000 | $4.5 million |
| [Spyre Therapeutics Inc](https://specstream.ai/data/institutional-holders/spyre-therapeutics-inc-00773j202) | COM NEW | 50,000 | $4.4 million |
| [Tango Therapeutics Inc](https://specstream.ai/data/institutional-holders/tango-therapeutics-inc-87583x109) | COM | 100,000 | $3.1 million |
| [Celcuity Inc](https://specstream.ai/data/institutional-holders/celcuity-inc-15102kab6) | NOTE 0.250% 8/0 (principal) | 2,500,000 | $2.8 million |
| [Super Micro Computer Inc](https://specstream.ai/data/institutional-holders/super-micro-computer-inc-86800u500) | 7 DEP CM SR A WI | 50,000 | $2.6 million |
| [Legend Biotech Corp](https://specstream.ai/data/institutional-holders/legend-biotech-corp-52490g102) | SPONSORED ADS | 85,385 | $2.5 million |
| [Alphabet Inc](https://specstream.ai/data/institutional-holders/alphabet-inc-02079k305) | CAP STK CL A | 6,000 | $2.1 million |
| [Alphabet Inc](https://specstream.ai/data/institutional-holders/alphabet-inc-02079k107) | CAP STK CL C | 6,000 | $2.1 million |
| [Uniqure NV](https://specstream.ai/data/institutional-holders/uniqure-nv-n90064101) | SHS | 45,000 | $2.1 million |
| [Innio NV](https://specstream.ai/data/institutional-holders/innio-nv-n52a8c105) | ORDINARY SHARES | 47,650 | $1.9 million |
| [Acadia Rlty TR](https://specstream.ai/data/institutional-holders/acadia-rlty-tr-004239109) | COM SH BEN INT | 85,385 | $1.8 million |
| [Pattern Group Inc](https://specstream.ai/data/institutional-holders/pattern-group-inc-70339w104) | COM SER A | 64,039 | $1.6 million |
| [Purecycle Technologies Inc](https://specstream.ai/data/institutional-holders/purecycle-technologies-inc-74623vad5) | NOTE 4.750% 7/0 (principal) | 1,500,000 | $1.5 million |
| [Moonlake Immunotherapeutics](https://specstream.ai/data/institutional-holders/moonlake-immunotherapeutics-61559x104) | CLASS A ORD | 75,000 | $1.5 million |
| [Whitehawk Minerals Corp](https://specstream.ai/data/institutional-holders/whitehawk-minerals-corp-96524t101) | CL A | 51,232 | $1.4 million |
| [Taysha Gene Therapies Inc](https://specstream.ai/data/institutional-holders/taysha-gene-therapies-inc-877619106) | COM SHS | 200,000 | $1.4 million |
| [Imagenebio Inc](https://specstream.ai/data/institutional-holders/imagenebio-inc-45175g207) | COM | 192,344 | $1.1 million |
| [Nuvation Bio Inc](https://specstream.ai/data/institutional-holders/nuvation-bio-inc-67080naa9) | NOTE 0.750% 7/0 (principal) | 1,000,000 | $1.1 million |
| [Kardigan Inc](https://specstream.ai/data/institutional-holders/kardigan-inc-485925101) | COM | 42,693 | $1 million |

## Positions exited in Q2 2026

43 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then. The 25 largest are shown.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| Terns Pharmaceuticals Inc | COM | 300,000 | $15.8 million |
| [Nextera Energy Inc](https://specstream.ai/data/institutional-holders/nextera-energy-inc-65339f655) | UNIT 02/15/2029 | 299,970 | $15.2 million |
| [Medline Inc](https://specstream.ai/data/institutional-holders/medline-inc-58507v107) | COM CL A | 300,000 | $13.4 million |
| [NRG Energy Inc](https://specstream.ai/data/institutional-holders/nrg-energy-inc-629377508) | COM NEW | 85,000 | $12.4 million |
| [Forgent Power Solutions Inc](https://specstream.ai/data/institutional-holders/forgent-power-solutions-inc-34631f102) | COM SHS CL A | 350,000 | $10.2 million |
| [Nektar Therapeutics](https://specstream.ai/data/institutional-holders/nektar-therapeutics-640268306) | COM NEW | 100,000 | $7.2 million |
| [Cytokinetics Inc](https://specstream.ai/data/institutional-holders/cytokinetics-inc-23282w605) | COM NEW | 100,000 | $6.6 million |
| [Joby Aviation Inc](https://specstream.ai/data/institutional-holders/joby-aviation-inc-47775aaa9) | NOTE 0.750% 2/1 | 7,000,000 | $5.9 million |
| [PPL Corp](https://specstream.ai/data/institutional-holders/ppl-corp-69351t866) | UNIT 02/15/2029 | 101,300 | $5.2 million |
| [Bridgebio Pharma Inc](https://specstream.ai/data/institutional-holders/bridgebio-pharma-inc-10806x102) | COM | 67,139 | $5 million |
| [Oracle Corp](https://specstream.ai/data/institutional-holders/oracle-corp-68389x204) | 6.5 DEP CUM SR D | 100,000 | $4.5 million |
| [Evommune Inc](https://specstream.ai/data/institutional-holders/evommune-inc-30054y107) | COM SHS | 179,340 | $4.1 million |
| [KKR & Co Inc](https://specstream.ai/data/institutional-holders/kkr-co-inc-48251w500) | 6.25 CON SER D | 100,000 | $4 million |
| [Ast Spacemobile Inc](https://specstream.ai/data/institutional-holders/ast-spacemobile-inc-00217d100) | COM CL A | 45,000 | $3.7 million |
| Zenas Biopharma Inc | NOTE 2.500% 4/0 | 3,152,000 | $3.2 million |
| [Sandisk Corp](https://specstream.ai/data/institutional-holders/sandisk-corp-80004c200) | COM | 5,000 | $3.2 million |
| [Veradermics Inc](https://specstream.ai/data/institutional-holders/veradermics-inc-922967104) | COMMON STOCK | 50,000 | $3.2 million |
| [Zenas Biopharma Inc](https://specstream.ai/data/institutional-holders/zenas-biopharma-inc-98937l105) | COM | 150,000 | $2.9 million |
| [Kymera Therapeutics Inc](https://specstream.ai/data/institutional-holders/kymera-therapeutics-inc-501575104) | COM | 35,100 | $2.9 million |
| [Ambiq Micro Inc](https://specstream.ai/data/institutional-holders/ambiq-micro-inc-023193105) | COMMON STOCK | 103,756 | $2.6 million |
| [Minimed Group Inc](https://specstream.ai/data/institutional-holders/minimed-group-inc-60365f109) | COM | 175,000 | $2.6 million |
| [Figure Technology Solutio](https://specstream.ai/data/institutional-holders/figure-technology-solutio-349381103) | COM CL A | 76,520 | $2.6 million |
| [Spyglass Pharma Inc](https://specstream.ai/data/institutional-holders/spyglass-pharma-inc-85220g109) | COM SHS | 95,000 | $2.5 million |
| [Structure Therapeutics Inc](https://specstream.ai/data/institutional-holders/structure-therapeutics-inc-86366e106) | SPONSORED ADS | 50,000 | $2.4 million |
| [Crispr Therapeutics AG](https://specstream.ai/data/institutional-holders/crispr-therapeutics-ag-h17182108) | NAMEN AKT | 50,000 | $2.4 million |

## Also on SpecStream

- [Monashee Investment Management LLC Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1627608/000117266126003357/0001172661-26-003357-index.htm)
- [Monashee Investment Management LLC investment adviser record (Form ADV)](https://specstream.ai/data/investment-advisers/firm/monashee-investment-management-llc-163148)
- [Largest 13F filers in Massachusetts](https://specstream.ai/data/institutional-holdings/state/massachusetts)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Boston, Massachusetts

- [Investment management firms in Boston, Massachusetts](https://specstream.ai/data/businesses/investment-management-firms/boston-massachusetts-united-states)
- [Language schools in Boston, Massachusetts](https://specstream.ai/data/businesses/language-schools/boston-massachusetts-united-states)
- [Advertising agencies in Boston, Massachusetts](https://specstream.ai/data/businesses/advertising-agencies/boston-massachusetts-united-states)
- [Home cleaning companies in Boston, Massachusetts](https://specstream.ai/data/businesses/home-cleaning-companies/boston-massachusetts-united-states)
- [Security companies in Boston, Massachusetts](https://specstream.ai/data/businesses/security-companies/boston-massachusetts-united-states)
- [Educational research institutes in Boston, Massachusetts](https://specstream.ai/data/businesses/educational-research-institutes/boston-massachusetts-united-states)
